Revista Mexicana de Oftalmología

Register      Login

VOLUME 97 , ISSUE 2E ( March-April, 2023 ) > List of Articles


Bacterial Etiology of Eye Infections and Antibiotic Resistance Patterns of Acinetobacter Spp.: A Review

Francisca Cea, Barbara Vargas-Aro, Marcelo Marín-Cornuy, Andrés Opazo, Patricia Aguila-Torres

Keywords : Acinetobacter, Drug resistance, Multiresistance, Ocular infection

Citation Information : Cea F, Vargas-Aro B, Marín-Cornuy M, Opazo A, Aguila-Torres P. Bacterial Etiology of Eye Infections and Antibiotic Resistance Patterns of Acinetobacter Spp.: A Review. 2023; 97 (2E):55-60.

DOI: 10.5005/rmo-11013-0024

License: CC BY-NC-ND 4.0

Published Online: 13-07-2023

Copyright Statement:  Copyright © 2023; Sociedad Mexicana de Oftalmología.


Purpose: This work aims to inform about the role of Acinetobacter spp. in ocular infections highlighting the microbial multi-resistance, based on the scientific evidence of a decade. Methods: A bibliographic review was carried out based on different electronic databases such as: Pubmed, Scopus and Web of Sciences with emphasis on ocular pathologiescaused by bacteria of the Acinetobacter genus, their treatment and antibiotic resistance. Results: 24 articles from indexed journals were included in the databases from January 2012 to January 2021 that met the inclusion and exclusion criteria. Conclusions: It is advisable to detect the etiological agent and perform antimicrobial susceptibility tests, since they are the basis for an effective treatment, also helping to reduce the future appearance of multi-resistant strains. According to the information collected on pharmacological therapy, the use of fluoroquinolones has good activity against Acinetobacter, proving to be the drug that presented the highest susceptibility efficacy against this pathogen. Despite the good response to the management of ocular infections, it is necessary to carry out more controlled and randomized studies in this to search for new antibacterial therapies.

PDF Share
  1. Ibrahim ME, Abbas M, Al-Shahrai AM, Elamin BK. Phenotypic Characterization and Antibiotic Resistance Patterns of Extended-Spectrum β -Lactamase- and AmpC β -Lactamase-Producing Gram-Negative Bacteria in a Referral Hospital, Saudi Arabia. Can J Infect Dis Med Microbiol 2019;2019:1–9. DOI: 10.1155/2019/6054694.
  2. Jhingan M, Balakrishnan D, Rani PK, Tyagi M, Joseph J. Microbiological Characteristics and Clinical Outcomes of Acinetobacter spp. Endophthalmitis with the First Reported Case of Acinetobacter haemolyticus Endophthalmitis. Semin Ophthalmol 2018;33:477–81. DOI: 10.1080/08820538.2017.1301498.
  3. Roy R, Das D, Kumar S, Mukherjee A. Postcataract surgery endophthalmitis caused by acinetobacter lwoffii. Middle East Afr J Ophthalmol 2015;22:253–4. DOI: 10.4103/0974-9233.151974.
  4. Goudarzi H, Mirsamadi ES, Ghalavand Z, Vala MH, Mirjalali H, Hashemi A, et al. Molecular detection of metallo-beta-lactamase genes in clinical isolates of Acinetobacter baumannii. J Pure Appl Microbiol 2015;9:145–51.
  5. Talreja D, Muraleedharan C, Gunathilaka G, Zhang Y, Kaye KS, Walia SK. Propiedades de virulencia del ocular resistente a múltiples fármacos Aislamientos de Acinetobacter baumannii 2014;39:695–704.
  6. Horozoglu F, Metan G, Sever O, Percin D, Topal CS, Gonen T, et al. Intravitreal tigecycline treatment in experimental Acinetobacter baumannii endophthalmitis. J Chemother 2012;24:101–6. DOI: 10.1179/1120009X12Z.00000000018.
  7. Alav I, Sutton JM, Rahman KM. Role of bacterial efflux pumps in biofilm formation. J Antimicrob Chemother 2018;73:2003–20. DOI: 10.1093/jac/dky042.
  8. Tsiatsiou O, Iosifidis E, Katragkou A, Dimou V, Sarafidis K, Karampatakis T, et al. Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. Eur J Pediatr 2015;174:65–74. DOI: 10.1007/s00431-014-2365-8.
  9. WHO. Comprehensive review of the WHO Global Action Plan on Antimicrobial Resistance. vol. 1. Geneve: 2021.
  10. Soltani B, Heidari H, Ebrahim-Saraie HS, Hadi N, Mardaneh J, Motamedifar M. Molecular characteristics of multiple and extensive drug-resistant acinetobacter baumannii isolates obtained from hospitalized patients in Southwestern Iran. Infez Med 2018;26:67–76.
  11. Konai MM, Pakrudheen I, Barman S, Sharma N, Tabbasum K, Garg P, et al. Cyclam-based antibacterial molecules eradicate Gram-negative superbugs with potent efficacy against human corneal infection. Chem Commun 2020;56:2147–50. DOI: 10.1039/c9cc06967d.
  12. Mayandi V, Xi Q, Goh ETL, Koh SK, Toh TYJ, Barathi VA, et al. Rational Substitution of ε-Lysine for α-Lysine Enhances the Cell and Membrane Selectivity of Pore-Forming Melittin. Jounal Med Chem 2020;63:3522–37. DOI: 10.1021/acs.jmedchem.9b01846.
  13. Thakuria B, Lahon K. The beta lactam antibiotics as an empirical therapy in a developing country: An update on their current status and recommendations to counter the resistance against them. J Clin Diagnostic Res 2013;7:1207–14. DOI: 10.7860/JCDR/2013/5239.3052.
  14. Roy R, Panigrahi P, Malathi J, Pal SS, Nandi K, Patil A, et al. Endophthalmitis caused by Acinetobacter baumanni: A case series. Eye 2013;27:450–2. DOI: 10.1038/eye.2012.277.
  15. Clemens LE, Jaynes J, Lim E, Kolar SS, Reins RY, Baidouri H, et al. Designed host defense peptides for the treatment of bacterial keratitis. Investig Ophthalmol Vis Sci 2017;58:6273–81. DOI: 10.1167/iovs.17-22243.
  16. Chen DQ, Jiang YT, Feng DH, Wen SX, Su DH, Yang L. Integron mediated bacterial resistance and virulence on clinical pathogens. Microb Pathog 2018;114:453–7. DOI: 10.1016/j.micpath.2017.12.029.
  17. Adeluola AO, Oyedeji KS, Mendie UE, Johnson JR, Porter JR. Detection, inhibition and molecular analysis of multidrug resistant aerobic gram-negative clinical isolates from a tertiary hospital in Nigeria. African J Biomed Res 2018;21:15–21.
  18. Murali S, Jambulingam M, Tiru V, Kulanthai LT, Rajagopal R, Padmanaban P, et al. A Study on Isolation Rate and Prevalence of Drug Resistance among Microorganisms Isolated from Multiorgan Donor and Donor Corneal Rim along with a Report on Existence of bla NDM-1 among Indian Population. Curr Eye Res 2012;37:195–203. DOI: 10.3109 / 02713683.2011.643270.
  19. Jan-Bond C, Norazah AR, Sree-Kumar P, Zunaina E, Fazilawati Q. Infected ptosis surgery – a rare complication from a multidrug-resistant organism. Clin Ophthalmol 2015;9:721–4. DOI: 10.2147/OPTH.S81158.
  20. Kaliamurthy J, Kalavathy CM, Parmar P, Nelson Jesudasan CA, Thomas PA. Spectrum of bacterial keratitis at a tertiary eye care centre in India. Biomed Res Int 2013;2013:1–8. DOI: 10.1155/2013/181564.
  21. Hasby Saad MA, Khalil HSM. Biofilm testing of microbiota: An essential step during corneal scrap examination in Egyptian acanthamoebic keratitis cases. Parasitol Int 2018;67:556–64. DOI: 10.1016/j.parint.2018.05.001.
  22. Li S, Zhong J, Tan Y, Deng Y, Huang H, Wang B, et al. Microbiological Screening of Hypothermic Preserved Donor Corneas in Keratoplasty. Curr Eye Res 2019;44:1067–74. DOI: 10.1080/02713683.2019.1616766.
  23. Naik MN, Vasanthapuram VH, Joseph J, Murthy SI. Microbial Keratitis in Thyroid Eye Disease: Clinical Features, Microbiological Profile, and Treatment Outcome. Ophthal Plast Reconstr Surg 2019;35:543–8. DOI: 10.1097/IOP.0000000000001361.
  24. Abdullah FE, Khan MI, Waheed S. Current pattern of antibiotic resistance of clinical isolates among conjunctival swabs. Pakistan J Med Sci 2013;29:81–4. DOI: 10.12669/pjms.291.2566.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.